Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-05
1997-11-25
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3147
Patent
active
056913508
ABSTRACT:
The present invention concerns the use of Linomide.RTM. or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of retrovirus infections. Specifically the invention concerns the treatment of HIV infections.
REFERENCES:
patent: 4547511 (1985-10-01), Eriksoo
Larsson et al., Int. J. Immunopharmacol., 9:425 (1987).
Carlsten H. et al., APMIS, 97:728 (1989).
Kalland et al., J. Immunol., 134:3956 (1985).
Kalland et al., J. Immunol., 144:4472-6 (1990).
Namikawa et al., Science, 242:1684-6 (1988).
Putkonen et al, J. AIDS Res., 2:359-365 (1989).
Thorstensson, et al., J. AIDS, "A capture immunoassay for detection of HIV-2/SIV Antigen" in press 1989.
Kalland, STN International, File CA, Chemical Abstracts, vol. 103, No. 15, Oct. 14, 1985.
Werner, Drugs of Today, vol. 26, No. 4, 1990, pp. 269-277.
St. Georgieu Vassil, Trends in Pharmacological Sciences, vol. 9, No. 12, 1988, p. 446-451.
Montagnier, Ann. Virol. Inst. Pasteur 135 E, pp. 119-134 (1984).
Guyader, Nature 326, p. 662 (1987).
Koff and Hoth, Science 241 , pp. 426-432 (1988).
Gottlieb, "Immunotherapy of the acquired immune deficiency syndrome", In: Gallin JI, Fauci AS eds. New York: Raven Press, 5:149-70 (1985).
Lotze, In: De Vita VT, et al., eds., AIDS Etiology, Diagnosis Treatment and Prevention, New York, Lippincott JB Company, pp. 235-263 (1985).
Popovic et al., Science 224, pp. 497-500 (1984).
Ilbaeck et al., File CA, Chemical Abstracts, vol. 110, 205297p, 1989.
Ilbaeck et al., File CA, Chemical Abstracts, vol. 110, 88192n, 1989.
Morahan et al., File CA, Chemical Abstracts, vol. 109, 122145r, 1988.
Morahan et al., "Immunopharmacology of infectious disease: Vaccine Adjuvants and Modulators of Non-Specific Resistance", pp. 313-324, 1987.
Vella et al., "Survial of Zidovudine-Treated Patients with Aids Compared with That of Contemporary Untreated Patients", JAMA, Mar., 1992, vol. 267, No. 9, pp. 1232-1236.
Montagnier, et al., Ann. Virol. (Inst. Pasteur) 135 E, 119-134, 1984.
Davis, Microbiology, Seconc Edition, Chapter 55, pp. 1280-1287.
McKinlay, Scand J. Infect Dis --Suppl. vol. 88, pp. 109-115, 1993.
St. Georgieu, Trends in Pharmacological Sciences, vol. 9, No. 12, 1988, pp. 446-451.
Kalland et al., J. Immunol. 134:3956, 1985.
Carlsten H. et al., APMIS, 97:728, 1989.
Koff and Hoth, Science, vol. 241, pp. 426-432, 1988.
Gallo et al., Science, vol. 224, pp. 500-503, 1984.
Popovic et al., Science, vol. 224, pp. 497-500, 1984.
Guyader, Nature, vol. 326, p. 662, 1987.
Lotze, In: De Vita VT, et al., eds., AIDS Etiology, Diagnosis, Treatment and Prevention, New York, Lippincott JB Company, pp. 235-263, 1985.
Larsson et al., Int. J. Immunopharmacol., 9:425, 1987.
Kalland et al., J. Immunol., 144:4472-6, 1990.
Namikawa et al., Science, 242:1684-6, 1988.
Thorstensoon, et al., Journal of Acquired Immunodeficiency Syndrome, "A capture immunoassay for detection of HIV-2/SIV Antigen" 4: 374-379, 1991.
Putkonen, Journal of Acquired Immune Deficiency Syndrome, 2:359-365, 1989.
Putkonen, "Monkey Models for Evaluation of HIV Vaccines", Doctoral Thesis, Dept. of Immunology, National Bacteriological Laboratory, Department of Virology, Karolinska Institute, 1991.
Cohen, Science, vol. 260, p. 157, Apr., 1993.
Ruedy et al., AIDS, 7:189-196, 1993 (MEDLINE Abstracts).
Van Rompay et al, Antimicrobial Agents and Chemotherapy, 36:2381-2386, 1992. (MEDLINE Abstracts).
McClure, Annuals of the N.Y. Academy of Science, 616:287-298, 199 (MEDLINE Abstracts) 1989.
Skowron, Hosp-Pract-Off-Ed, Suppl 2: 5-13, Aug., 1992 (MEDLINE Abstracts).
Ilback, The Journal of Immunology, vol. 142, pp. 3225-3228, No. 9, May, 1989.
Ilback, Antiviral Research, 10, pp. 129-140, 1988.
Bottiger, et al., AIDS Research in Human Retroviruses, vol. 8, No. 7, pp. 1235-1238, 1992.
Lundgren et al., Antiviral Chemistry and Chemotherapy, 5:299-306, 1990.
Putkonen, et al., Journal of Acquired Immune Deficiency Syndromes, "Experimental Infection of Cynomolgus Monkeys", 2:366-373, 1989.
Putkonen, et al., Aids Research and Human Retroviruses, "Vaccine Protection Against HIV-2 Infection in Cynomolgus Monkeys", vol. 7, No. 3, 1991.
Feichtinger, et al., American Journal of Pathology, vol. 137, No. 6, pp. 1311-1315, 1990.
Putkonen, et al, AIDS, vol. 4, No. 8, pp. 784-789.
Morahan, Prog. Leukoyte Biology, 6:313-324, 1987.
Ilbaeck et al 110 CA: 205297p 1989 (1989).
Ilbaeck et al 110 CA 88192n 1989 (1988).
Morahan et al 109 CA:122145r 1987.
Kalland Terje
Nilsson Bo
Kabi Pharmacia AB
Travers Russell
LandOfFree
Use of linomide for treatment of retrovirus infections specifica does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of linomide for treatment of retrovirus infections specifica, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of linomide for treatment of retrovirus infections specifica will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107396